Watch as our multidisciplinary panel of experts examine recently published trial data, novel systemic therapies, MR-guided radiation therapy, minimally invasive approaches to pancreatic surgery, irreversible electroporation (IRE) for pancreatic cancer, and more.

Upon completion of this symposium, participants should be better able to:

• Assess patient selection for surgery versus nonsurgical ablative therapies for pancreatic cancer patients.
• Implement approaches of selection of systemic therapies for pancreatic cancer patients.
• Compare differences between local ablative therapies for patients with unresectable pancreatic cancer.

Faculty:

Michael Chuong, MD, FACRO
Antonio Ucar, MD
Domenech Asbun, MD, FACS
Govindarajan Narayanan, MD

Originaly broadcasted live on July 24th.